Serum Immunoglobulin Response and Protection from Homologous Challenge by Proteus mirabilis in a Mouse Model of Ascending Urinary Tract Infection
- 1 December 1999
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 67 (12) , 6683-6687
- https://doi.org/10.1128/iai.67.12.6683-6687.1999
Abstract
We tested the hypothesis that experimental Proteus mirabilis urinary tract infection in mice would protect against homologous bladder rechallenge. Despite production of serum immunoglobulin G (IgG) and IgM (median titers of 1:320 and 1:80, respectively), vaccinated (infected and antibiotic-cured) mice did not show a decrease in mortality upon rechallenge; the survivors experienced only modest protection from infection (mean log 10 number of CFU of P. mirabilis Nal r HI4320 per milliliter or gram in vaccinated mice versus sham-vaccinated mice: urine, 100-fold less [3.5 versus 5.5; P = 0.13]; bladder, 100-fold less [3.1 versus 5.1; P = 0.066]; kidneys, 40-fold less [2.7 versus 4.3; P = 0.016]). Western blots using protein from the wild-type strain and isogenic mutants demonstrated antibody responses to MR/P and PMF fimbriae and flagella. There was no correlation between serum IgG or IgM levels and protection from mortality or infection. There was a trend toward elevated serum IgA titers and protection from subsequent challenge ( P ≥ 0.09), although only a few mice developed significant serum IgA levels. We conclude that prior infection with P. mirabilis does not protect significantly against homologous challenge.Keywords
This publication has 37 references indexed in Scilit:
- Long-term follow up to determine the prognostic value of imaging after urinary tract infections. Part 2: Scarring.Archives of Disease in Childhood, 1995
- Natural History of Recurrent Urinary Tract Infections in WomenClinical Infectious Diseases, 1990
- Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.Journal of Clinical Investigation, 1989
- Recurrent Urinary Tract Infections in Female Patients: An Overview of Management and TreatmentClinical Infectious Diseases, 1987
- The Combination of Pivampicillin and Pivmecillinam versus Pivampicillin Alone in the Treatment of Acute PyelonephritisScandinavian Journal of Infectious Diseases, 1986
- Timentin versus piperacillin in the therapy of serious urinary tract infectionsThe American Journal of Medicine, 1985
- Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis--an explanationJournal of Medical Microbiology, 1983
- A Prospective Microbiologic Study of Bacteriuria in Patients with Chronic Indwelling Urethral CathetersThe Journal of Infectious Diseases, 1982
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Systemic and Urinary Immune Response in Experimental E. coli Pyelonephritis of MiceInternational Archives of Allergy and Immunology, 1973